The Lancet Commission on diagnostics: transforming access to diagnostics

KA Fleming, S Horton, ML Wilson, R Atun, K DeStigter… - The Lancet, 2021 - thelancet.com
Executive summary At the end of 2019, the first reports of a new respiratory virus appeared
in China. The subsequent COVID-19 pandemic has affected every person, in every country …

Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets

CW Spearman, M Afihene, R Ally, B Apica… - The lancet …, 2017 - thelancet.com
The WHO global health sector strategy on viral hepatitis, created in May, 2016, aims to
achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in …

[图书][B] Global hepatitis report 2017

World Health Organization - 2017 - apps.who.int
Under the terms of this licence, you may copy, redistribute and adapt the work for
noncommercial purposes, provided the work is appropriately cited, as indicated below. In …

[图书][B] WHO guidelines on hepatitis B and C testing

World Health Organization - 2017 - apps.who.int
Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

Requirements for global elimination of hepatitis B: a modelling study

S Nayagam, M Thursz, E Sicuri, L Conteh… - The Lancet Infectious …, 2016 - thelancet.com
Background Despite the existence of effective prevention and treatment interventions,
hepatitis B virus (HBV) infection continues to cause nearly 1 million deaths each year. WHO …

The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda

E Martyn, S Eisen, N Longley, P Harris, J Surey… - Elife, 2023 - elifesciences.org
Hepatitis B virus (HBV) infection represents a significant global health threat, accounting for
300 million chronic infections and up to 1 million deaths each year. HBV disproportionately …

Hepatitis B virus infection

MF Yuen, DS Chen, GM Dusheiko… - Nature reviews Disease …, 2018 - nature.com
Hepatitis B virus (HBV) is a hepatotropic virus that can establish a persistent and chronic
infection in humans through immune anergy. Currently, 3.5% of the global population is …

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

GS Cooke, I Andrieux-Meyer, TL Applegate… - The lancet …, 2019 - thelancet.com
Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Burden of non-communicable diseases from infectious causes in 2017: a modelling study

MM Coates, A Kintu, N Gupta, EB Wroe… - The Lancet Global …, 2020 - thelancet.com
Summary Background Non-communicable diseases (NCDs) cause a large burden of
disease globally. Some infectious diseases cause an increased risk of developing specific …

[HTML][HTML] The use of cost-effectiveness thresholds for evaluating health interventions in low-and middle-income countries from 2015 to 2020: a review

J Kazibwe, A Gheorghe, D Wilson, F Ruiz, K Chalkidou… - Value in Health, 2022 - Elsevier
Objectives Evidence-informed priority setting, in particular cost-effectiveness analysis (CEA),
can help target resources better to achieve universal health coverage. Central to the …